Personalized Prediction of Lifetime Benefits with Statin Therapy for Asymptomatic Individuals: A Modeling Study
Table 2
Predicted outcomes and changes with statin therapy for the study population (n = 2,428) aged 55 y and older, free of cardiovascular disease and symptoms at baseline.